Clinical Data, Inc. to Sell Cogenics Division to Beckman Coulter, Inc.

NEWTON, Mass. & ORANGE COUNTY, Calif.--(BUSINESS WIRE)--Clinical Data, Inc. (NASDAQ: CLDA) and Beckman Coulter, Inc. (NYSE: BEC) announced today that the companies have signed a definitive agreement for Beckman Coulter to acquire Clinical Data’s Cogenics division, a global leader in outsourced genomics services, for approximately $17.0 million. The sale will complete a key element of Clinical Data’s strategic initiative to monetize non-core assets and focus resources on advancing the Company’s two late-stage targeted therapeutic programs. The acquisition of Cogenics complements Beckman Coulter’s Agencourt Biosciences’ business, which delivers genomic services and nucleic acid purification products, and expands its reach into new territories.